BEAPHAR FLEA & TICK COLLAR FOR DOGS

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)

Mevcut itibaren:

Beaphar B.V.

ATC kodu:

QP53AF03

INN (International Adı):

DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)

Doz:

3.9 Grams

Farmasötik formu:

Collar

Reçete türü:

CAM-Companion Animal Medicine

Terapötik grubu:

Canine

Terapötik alanı:

Dimpylate

Terapötik endikasyonlar:

Ectoparasiticide

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2012-06-15

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar Flea & Tick Collar for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ONE COLLAR OF 65 CM LENGTH (26 G) CONTAINS:
ACTIVE SUBSTANCE:
Dimpylate (as stabilized diazinon at 92% diazinon) 3.9 g
EXCIPIENTS:
Carbon black (E153) 0.004 g
For a full list of excipeints, see section 6.1
3 PHARMACEUTICAL FORM
Collar
Black, PVC collar
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of dogs infested with fleas (_Ctenocephalides felis_) and ticks (_Ixodes ricinus_).
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance, or to any of the excipients.
Do not use on sick and recovering dogs.
Do not use in dogs with known liver disorder.
Do not use in pregnant dogs.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
When fitting, ensure that the collar is not too tight. Loosen the collar as the dog grows bigger.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 22/11/2016_
_CRN 7024441_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Due to the potential risk of hypersensitivity developing in humans to dimpylate, unnecessary handling of this product
should be avoided.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
An intoxification typical for organophosphorus compounds occurs rarely. Rarely, local skin reaction at the site of collar
application may occur. Such reactions may be associated with either skin sensitivity to some of the substances in the collar
or an incorrect